ZEB1 and colonic neoplasm: VB significantly inhibits tumor cell metastasis and invasion by inhibiting Rac-1, hypoxia inducible factor-1α (HIF-1α), and Zeb-1 signaling pathways, which may be the most metastatic phenotype of colon cancer-suitable drug candidates.27